Effects of pre-emptive drug treatment on astrocyte activation in the cuneate nucleus following rat median nerve injury.

Abstract

In this study, we examined the relationship between astrocyte activation in the cuneate nucleus (CN) and behavioral hypersensitivity after chronic constriction injury (CCI) of the median nerve. In addition, we also examined the effects of pre-emptive treatment with a number of drugs on astrocyte activation and hypersensitivity development in this model. Using immunohistochemistry and immunoblotting, little glial fibrillary acidic protein (GFAP; an astrocyte marker) immunoreactivity was detected in the CN of the normal rats. As early as 3 days after CCI, there was a significant increase in GFAP immunoreactivity in the lesion side of CN, and this reached a maximum at 7 days, and was followed by a decline. Counting of GFAP-immunoreactive astrocytes revealed that astrocytic hypertrophy, but not proliferation, contributes to increased GFAP immunoreactivity. Furthermore, microinjection of the glial activation inhibitor, fluorocitrate, into the CN at 3 days after CCI attenuated injury-induced behavioral hypersensitivity in a dose-dependent manner. These results suggest that median nerve injury-induced astrocytic activation in the CN modulated the development of behavioral hypersensitivity. Animals received MK-801 (glutamate N-methyl-d-aspartate (NMDA) receptor antagonist), clonidine (alpha(2)-adrenoreceptor agonist), tetrodotoxin (TTX, sodium channel blocker) or lidocaine (local anesthetic) 30 min prior to median nerve CCI. Pre-treatment with MK-801, TTX, and 2% lidocaine, but not clonidine, attenuated GFAP immunoreactivity and behavioral hypersensitivity following median nerve injury. In conclusion, suppressing reactions to injury, such as the generation of ectopic discharges and activation of NMDA receptors, can decrease astrocyte activation in the CN and attenuate neuropathic pain sensations.

• Authors: Jiann-Jy Chen, June-Horng Lue, Lung-Huang Lin, Chun-Ta Huang, Rayleigh Ping-Ying Chiang, Chih-Li Chen, Yi-Ju Tsai
• Journal: Pain (Pain) Vol. 148 Issue 1 Pg. 158-166 (Jan 2010) ISSN: 1872-6623 [Electronic] United States
• PMID: 19954890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright 2009 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Chemical References

• Adrenergic alpha-Agonists
• Citrates
• Excitatory Amino Acid Antagonists
• Glial Fibrillary Acidic Protein
• Sodium Channel Blockers
• fluorocitrate
• Tetrodotoxin
• Dizocilpine Maleate
• Lidocaine
• Clonidine

Topics

• Adrenergic alpha-Agonists (pharmacology)
• Animals
• Astrocytes (drug effects, metabolism)
• Citrates (pharmacology)
• Clonidine (pharmacology)
• Disease Models, Animal
• Dizocilpine Maleate (pharmacology)
• Excitatory Amino Acid Antagonists (pharmacology)
• Glial Fibrillary Acidic Protein (metabolism)
• Hyperalgesia (drug therapy, physiopathology)
• Lidocaine
• Male
• Median Neuropathy (drug therapy, pathology)
• Medulla Oblongata (drug effects, pathology)
• Pain Threshold (drug effects, physiology)
• Rats
• Rats, Sprague-Dawley
• Sodium Channel Blockers (pharmacology)
• Tetrodotoxin (pharmacology)
• Time Factors
• Up-Regulation (drug effects, physiology)